Black Diamond Therapeutics Inc.

BDTX | NASDAQ

$1.98

+$0.03 (+1.54%)

Sep 22, 2026, 11:24 AM ET · Market open

Fiscal Year Period Ending	FY 2025 Dec 30, 2025	FY 2024 Dec 30, 2024	FY 2023 Dec 30, 2023	FY 2022 Dec 30, 2022	FY 2021 Dec 30, 2021	FY 2020 Dec 30, 2020
Revenue	70M	n/a	n/a	n/a	n/a	n/a
Cost of Revenue	325K	n/a	437K	n/a	n/a	n/a
Gross Profit	69.68M	n/a	-437K	n/a	n/a	n/a
Operating Income	19.87M	-78.78M	-86.46M	-92.83M	-126.87M	-69.57M
Interest Income	4.06M	2.18M	1.92M	2.03M	3.46M	4.04M
Pretax Income	22.37M	-69.68M	-82.44M	-91.17M	-125.6M	-67.25M
Net Income	22.37M	-69.68M	-82.44M	-91.17M	-125.6M	-67.25M
Selling & General & Admin	16.57M	27.47M	27.11M	28.39M	30.04M	21.36M
Research & Development	33.56M	51.31M	58.91M	64.44M	96.83M	48.21M
Other Expenses	-325K	n/a	n/a	n/a	n/a	n/a
Operating Expenses	49.81M	78.78M	86.02M	92.83M	126.87M	69.57M
Interest Expense	n/a	n/a	n/a	n/a	n/a	1K
Selling & Marketing Expenses	n/a	n/a	n/a	n/a	n/a	n/a
Cost & Expenses	50.13M	78.78M	86.46M	92.83M	126.87M	69.57M
Income Tax Expense	n/a	n/a	n/a	n/a	n/a	n/a
Shares Outstanding (Basic)	56.87M	55.03M	43.95M	36.23M	36.19M	32.91M
Shares Outstanding (Diluted)	57.56M	55.03M	43.95M	36.23M	36.19M	32.91M
EPS (Basic)	0.39	-1.27	-1.88	-2.52	-3.47	-2.04
EPS (Diluted)	0.39	-1.27	-1.88	-2.52	-3.47	-2.04
EBITDA	22.69M	-69.33M	-82.01M	-90.66M	-125.39M	-66.65M
EBIT	22.37M	-69.68M	-82.44M	-91.17M	-125.6M	-67.25M
Depreciation & Amortization	325K	343K	437K	508K	205K	600K